Dengvaxia is a live, attenuated vaccine, which means it uses a weakened form of the virus to stimulate an immune response. The vaccine is designed to prompt the body's immune system to recognize and fight off the dengue virus. By exposing the immune system to a controlled, non-threatening version of the virus, the vaccine helps build immunity against future infections.